3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
17
Lymphoma
12
Leukemia
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Hodgkin Disease
4
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hematologic Neoplasms
3
Graft vs Host Disease
3
Waldenstrom Macroglobulinemia
2
Myelodysplastic-Myeloproliferative Diseases
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Peripheral
2
Carcinoma, Renal Cell
2
Stomach Neoplasms
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Interventions
Rituximab
45
Cyclophosphamide
34
Doxorubicin
16
fludarabine
14
Prednisone
14
Vincristine
13
Etoposide
13
ibrutinib
10
Mycophenolic Acid
8
Bortezomib
8
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
Cytarabine
7
pembrolizumab
6
Immunotherapy, Adoptive
6
polatuzumab vedotin
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Vorinostat
5
Tacrolimus
5
Specimen Handling
5
CT-P10
5
obinutuzumab
4
ibritumomab tiuxetan
4
Nivolumab
4
Ifosfamide
4
Carmustine
4
Carboplatin
4
Antilymphocyte Serum
4
tafasitamab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, B-Cell
×
Pentostatin
×
Clear all
NCT00927797
2009-06-25
PERLL
Heidelberg University
Phase 2
Unknown
185 enrolled